Alto Neuroscience (ANRO) Non-Current Assets (2023 - 2026)

Alto Neuroscience's (ANRO) quarterly Non-Current Assets came in at $7.1 million in Q1 2026, down 15.0% year-on-year from $8.4 million in Q1 2025, and up 2.32% quarter-over-quarter from $7.0 million in Q4 2025.

Alto Neuroscience (ANRO) Non-Current Assets (2023 - 2026) Analysis & Trends

Alto Neuroscience has disclosed Non-Current Assets across 4 years of filings, most recently posting $7.1 million for Q1 2026.

  • Non-Current Assets for Q1 2026 came in at $7.1 million, down 15.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $29.7 million (up 11.52% YoY), and the FY2025 annual result was $7.0 million, down 15.04% from the prior year.
  • Non-Current Assets came in at $7.1 million for Q1 2026 at Alto Neuroscience, up from $7.0 million in the prior quarter.
  • In the past five years, Non-Current Assets ranged from a high of $8.4 million in Q1 2025 to a low of $1.2 million in Q4 2023.
  • The 4-year median for Non-Current Assets is $7.3 million (2025), against an average of $5.9 million.
  • Across the five-year window, Non-Current Assets surged 563.3% in 2024 and retreated 15.04% in 2025, its largest moves.
  • Alto Neuroscience's Non-Current Assets stood at $1.2 million in 2023, then soared by 563.3% to $8.2 million in 2024, then declined by 15.04% to $7.0 million in 2025, then gained by 2.32% to $7.1 million in 2026.
  • The last three Non-Current Assets figures came in at $7.1 million (Q1 2026), $7.0 million (Q4 2025), and $7.6 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Alterity Therapeutics 762,369.55 Bn 762,369.51 Bn - 62,953.78
2 Belite Bio 55,096.00 Bn 55,096.00 Bn - 289.41 Mn
3 Quantum Biopharma 17,755.80 Bn 17,755.79 Bn - 4.56 Mn
4 Legend Biotech 3,486.00 Bn 3,485.71 Bn 242.10 Mn 486.60 Mn
5 Akari Therapeutics 1,737.42 Bn 1,737.41 Bn - 30.30 Mn
6 Evaxion A 1,551.28 Bn 1,551.26 Bn - -
7 Psyence Biomedical 227.32 Bn 227.31 Bn - 5.18 Mn
8 Vertex Pharmaceuticals 110.84 Bn 103.59 Bn 2.59 Bn 14.75 Bn
9 Abivax 91.71 Bn 91.71 Bn - 39.71 Mn
10 Alto Neuroscience 643.06 Mn 379.30 Mn - 7.13 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 7.13 Mn
Dec 31, 2025 6.97 Mn
Sep 30, 2025 7.56 Mn
Jun 30, 2025 8.03 Mn
Mar 31, 2025 8.39 Mn
Dec 31, 2024 8.21 Mn
Sep 30, 2024 8.08 Mn
Jun 30, 2024 1.95 Mn
Mar 31, 2024 1.61 Mn
Dec 31, 2023 1.24 Mn